MUSTANG BIO, INC. Income Tax Examination, Penalties and Interest Expense
MUSTANG BIO, INC. (MBIO) reported Income Tax Examination, Penalties and Interest Expense of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Expense Statement › Interest Expense
us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense · last filed 2025-03-28
- MUSTANG BIO, INC. income tax examination, penalties and interest expense for fiscal 2024 was $0.00.
- MUSTANG BIO, INC. income tax examination, penalties and interest expense for fiscal 2023 was $0.00.
- MUSTANG BIO, INC. income tax examination, penalties and interest expense for fiscal 2022 was $0.00.
- MUSTANG BIO, INC. income tax examination, penalties and interest expense for fiscal 2021 was $0.00.
| Period end | Income Tax Examination, Penalties and Interest Expense 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-28 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-28 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-11 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-24 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |